A

Aimmune Therapeutics

334 employees

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Desensitization
Therapeutics
Oral Immunotherapy
Pharmaceutical
Drug Development
Food Allergies

Date founded

2011

Funding rounds raised

Total raised

$80M

from 6 investors over 6 rounds

A

Aimmune Therapeutics raised $80M on March 12, 2015

Investors: RA Capital Management, L.P., Aisling Capital, Adage Capital Management, Foresite Capital and Longitude Capital

A

Aimmune Therapeutics raised $17M on November 21, 2013

Investors: Longitude Capital

FAQ